Log In
BCIQ
Print this Print this
 

Galectin-3 (LGALS3)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Galectin-3 (LGALS3)

BCIQ
Print ChartPrint this
1 0 0 0 2 0 1 0 2 1 0 0 0 0 0 2 0 1 1 0
Phases of DevelopmentPreclinicalPhase IPhase I/IIMarketed
Cancer

0

1

1

0

Diagnostic

0

0

0

2

Hepatic

2

1

0

0

Pulmonary

2

0

1

0

Renal

1

0

0

0




 Products Targeting Galectin-3 (LGALS3)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

$444.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today